Co-Authors
This is a "connection" page, showing publications co-authored by Nicola Petrosillo and Mario Venditti.
Connection Strength
0.430
-
Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes. Clin Microbiol Infect. 2019 Apr; 25(4):474-480.
Score: 0.194
-
The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives. Expert Rev Anti Infect Ther. 2021 09; 19(9):1125-1134.
Score: 0.058
-
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study. J Infect. 2019 08; 79(2):130-138.
Score: 0.052
-
The current role of glycopeptides in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in not neutropenic adults: the viewpoint of a group of Italian experts. J Chemother. 2018 May; 30(3):157-171.
Score: 0.047
-
Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update. J Chemother. 2017 Aug; 29(4):197-214.
Score: 0.044
-
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014 Jan; 20 Suppl 1:1-55.
Score: 0.035